Stream Los Angeles News for free, 24/7, wherever you are. The Grail deal is the focus of a heated proxy fight between Illumina and activist investor Carl Icahn. Antitrust regulators in the U.S. and ...

In the week since Carl Icahn sent an open letter to Illumina shareholders to drum up support for a proxy battle, the fight between the billionaire activist investor and sequencing giant has only ...

San Diego gene-sequencing pioneer Illumina on Tuesday won its court fight against the European Union’s investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail, a ruling set to ...

March 15 (Reuters) - Billionaire investor Carl Icahn is urging life sciences company Illumina Inc ILMN.O to divest cancer test developer Grail Inc GRAL.O and said on ...

The Grail deal is the focus of a heated proxy fight between Illumina and activist investor Carl Icahn. Antitrust regulators in the U.S. and Europe also have ordered Illumina to divest the $7.1 billion ...